GenMont Biotech Incorporation (3164.TW)
TWD 19.95
(-0.5%)
TWD 19.95
(-0.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 318.01 Million | 368.54 Million | 427.92 Million | 325.19 Million | 346.24 Million | 406.53 Million |
| Cost of Revenue | 140.67 Million | 111.82 Million | 128.6 Million | 109.8 Million | 116.54 Million | 128.98 Million |
| Gross Profit | 177.33 Million | 256.71 Million | 299.32 Million | 215.39 Million | 229.7 Million | 277.54 Million |
| Operating Expenses | 204.2 Million | 196.53 Million | 170.98 Million | 145.03 Million | 152.93 Million | 154.72 Million |
| Selling, General and Administrative Expenses | 123.48 Million | 137.12 Million | 145.46 Million | 118.73 Million | 125.82 Million | 127 Million |
| Research and Development Expenses | 46.86 Million | 59.41 Million | 25.52 Million | 26.3 Million | 27.1 Million | 27.72 Million |
| Other Expenses | - | 239 Thousand | 13.13 Million | 3.85 Million | -744 Thousand | 4.11 Million |
| Cost and Expenses | 311.02 Million | 308.36 Million | 299.59 Million | 254.83 Million | 269.47 Million | 283.7 Million |
| Operating Income | 6.98 Million | 65.22 Million | 143.48 Million | 76.99 Million | 75.46 Million | 122.82 Million |
| Interest Expense | 973 Thousand | 755 Thousand | 766 Thousand | 806 Thousand | 776 Thousand | - |
| Income Tax Expense | 5.73 Million | 18.79 Million | 29.82 Million | 16.63 Million | 18.3 Million | 25.8 Million |
| Earnings before Tax | 28.16 Million | 66.25 Million | 139.42 Million | 76.84 Million | 75.54 Million | 123.9 Million |
| Net Income | 32.99 Million | 56.97 Million | 113.13 Million | 60.88 Million | 57.45 Million | 158.01 Million |
| Earnings Per Share Basic | 0.38 | 0.66 | 1.31 | 0.69 | 0.65 | 1.78 |
| Earnings Per Share Diluted | 0.38 | 0.66 | 1.30 | 0.69 | 0.64 | 1.77 |
| Weighted Average Shares Outstanding | 86.41 Million | 86.37 Million | 86.35 Million | 87.79 Million | 88.92 Million | 88.91 Million |
| Weighted Average Shares Outstanding (Diluted) | 86.57 Million | 86.66 Million | 86.74 Million | 88.05 Million | 89.25 Million | 89.37 Million |
| Gross Margin | 0.56 | 0.70 | 0.70 | 0.66 | 0.66 | 0.68 |
| EBIT Margin | 0.23 | 0.31 | 0.38 | 0.30 | 0.28 | 0.37 |
| Profit Margin | 0.10 | 0.15 | 0.26 | 0.19 | 0.17 | 0.39 |
| EBITDA | 71.76 Million | 115.64 Million | 164.62 Million | 98.58 Million | 98.06 Million | 143.91 Million |
| Earnings Before Tax Margin | 0.02 | 0.18 | 0.34 | 0.24 | 0.22 | 0.30 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 94.18 Million | 116.41 Million | 74.1 Million | 318.01 Million | 76.35 Million | 87.93 Million |
| Cost of Revenue | 43.2 Million | 46.05 Million | 30.18 Million | 140.67 Million | 26.53 Million | 32.46 Million |
| Gross Profit | 50.98 Million | 70.36 Million | 43.91 Million | 177.33 Million | 49.82 Million | 55.46 Million |
| Operating Expenses | 40.81 Million | 40.14 Million | 40.87 Million | 170.34 Million | 50.89 Million | 52.46 Million |
| Selling, General and Administrative Expenses | 27.93 Million | 29.39 Million | 28.46 Million | - | 39.57 Million | 39.76 Million |
| Research and Development Expenses | 12.87 Million | 10.75 Million | 12.41 Million | - | 11.31 Million | 12.69 Million |
| Other Expenses | 4.44 Million | 9.16 Million | -10.93 Million | 13.62 Million | 27.2 Million | -6.6 Million |
| Cost and Expenses | 84.01 Million | 86.2 Million | 71.06 Million | 311.02 Million | 77.42 Million | 84.93 Million |
| Operating Income | 10.17 Million | 30.21 Million | 3.03 Million | 6.98 Million | 27.99 Million | -1.6 Million |
| Interest Expense | 940 Thousand | 683 Thousand | 414 Thousand | 973 Thousand | 186 Thousand | 187 Thousand |
| Income Tax Expense | 4.12 Million | 9.1 Million | -551 Thousand | 5.73 Million | 4.23 Million | 768 Thousand |
| Earnings before Tax | 16.55 Million | 41.57 Million | -5.25 Million | 28.16 Million | 25.46 Million | 908 Thousand |
| Net Income | 14.67 Million | 34.74 Million | -2.01 Million | 32.99 Million | 23.87 Million | 2.88 Million |
| Earnings Per Share Basic | 0.17 | 0.40 | -0.02 | - | 0.28 | 0.03 |
| Earnings Per Share Diluted | 0.17 | 0.40 | -0.02 | - | 0.28 | 0.03 |
| Weighted Average Shares Outstanding | 86.51 Million | 86.51 Million | 86.51 Million | 86.41 Million | 86.41 Million | 86.37 Million |
| Weighted Average Shares Outstanding (Diluted) | 86.65 Million | 86.67 Million | 86.51 Million | 86.57 Million | 86.53 Million | 86.45 Million |
| Gross Margin | 0.54 | 0.60 | 0.59 | 0.56 | 0.65 | 0.63 |
| EBIT Margin | 0.30 | 0.41 | 0.28 | - | 0.58 | 0.15 |
| Profit Margin | 0.16 | 0.30 | -0.03 | 0.10 | 0.31 | 0.03 |
| EBITDA | 28.27 Million | 47.98 Million | 20.56 Million | - | 44.61 Million | 13.62 Million |
| Earnings Before Tax Margin | 0.11 | 0.26 | 0.04 | 0.02 | 0.37 | -0.02 |
688105
CHKEL
7939
ACLS
2340
EPAC